USD
+$0.00
(+0.00%
)At Close (As of Sep 16, 2025)
$100.48M
Market Cap
-
P/E Ratio
-2.63
EPS
$33.97
52 Week High
$1.14
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$1.1M |
Total Revenue | $0 |
Cost Of Revenue | $1.1M |
Costof Goods And Services Sold | $1.1M |
Operating Income | -$151M |
Selling General And Administrative | $72M |
Research And Development | $70M |
Operating Expenses | $150M |
Investment Income Net | - |
Net Interest Income | $8.5M |
Interest Income | $8.5M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.1M |
Income Before Tax | -$24M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$24M |
Comprehensive Income Net Of Tax | - |
Ebit | -$24M |
Ebitda | -$23M |
Net Income | -$24M |
Field | Value (USD) |
---|---|
Total Assets | $158M |
Total Current Assets | $137M |
Cash And Cash Equivalents At Carrying Value | $129M |
Cash And Short Term Investments | $129M |
Inventory | - |
Current Net Receivables | $947K |
Total Non Current Assets | $21M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $37K |
Intangible Assets Excluding Goodwill | $37K |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $7M |
Other Non Current Assets | - |
Total Liabilities | $12M |
Total Current Liabilities | $12M |
Current Accounts Payable | $7.7M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | - |
Total Non Current Liabilities | $79K |
Capital Lease Obligations | - |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | - |
Other Current Liabilities | $4.1M |
Other Non Current Liabilities | $79K |
Total Shareholder Equity | $146M |
Treasury Stock | - |
Retained Earnings | -$405M |
Common Stock | $48K |
Common Stock Shares Outstanding | $47M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$117M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $1.1M |
Capital Expenditures | $103K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$103K |
Cashflow From Financing | $124M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$24M |
Field | Value (USD) |
---|---|
Gross Profit | -$1.1M |
Total Revenue | $0 |
Cost Of Revenue | $1.1M |
Costof Goods And Services Sold | $1.1M |
Operating Income | -$151M |
Selling General And Administrative | $72M |
Research And Development | $70M |
Operating Expenses | $150M |
Investment Income Net | - |
Net Interest Income | $8.5M |
Interest Income | $8.5M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.1M |
Income Before Tax | -$24M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$24M |
Comprehensive Income Net Of Tax | - |
Ebit | -$24M |
Ebitda | -$23M |
Net Income | -$24M |
Field | Value |
---|---|
Ex Dividend Date | 2012-12-13 |
Declaration Date | None |
Record Date | None |
Payment Date | None |
Amount | 0.75 |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas.